Status:
COMPLETED
Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination
Lead Sponsor:
Murdoch Childrens Research Institute
Collaborating Sponsors:
Brockhoff Foundation Australia
Shepherd Foundation Australia
Conditions:
Cervical Cancer
Eligibility:
FEMALE
12-26 years
Phase:
PHASE3
Brief Summary
A research project is currently being undertaken looking at Human Papilloma Virus (HPV) vaccination in special risk groups. It aims to see if young women with a chronic illness respond well to the HPV...
Eligibility Criteria
Inclusion
- Females aged 12-26 years
- Have been diagnosed by a specialist with one of the six chronic medical conditions described:
- Paediatric Rheumatological Disease
- Inflammatory Bowel Disease
- Acute Lymphoblastic Leukaemia
- Solid Organ Transplant Recipients (kidney and liver)
- Chronic Renal Disease
- Bone Marrow Transplant
Exclusion
- Previous immunisation with HPV vaccine Recognised contraindication to the receipt of the vaccine e.g. anaphylaxis
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2011
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00964210
Start Date
March 1 2008
End Date
April 1 2011
Last Update
April 15 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Childrens Hospital
Melbourne, Victoria, Australia, 3152